The global pharmaceutical rapid microbiology testing market is expected to grow at a CAGR of 6.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for rapid microbiological testing in pharmaceutical industries due to the rising number of drug recalls and product recalls. Rapid microbiological testing helps in detecting microbial contamination in raw materials, process water, environment monitoring, and other applications such as bioburden assessment and sterility testing.
The immunology based methods segment accounted for the largest share of this market in 2018 owing to its high accuracy level and low cost-effectiveness. The nucleic acid based amplification tests segment is expected to grow at a CAGR of 7% during the forecast period owing to its high sensitivity level which helps detect even low levels of microorganisms present in samples.
- The increasing number of people suffering from chronic diseases such as diabetes, cancer, and heart disease is driving the growth of the pharmaceutical rapid microbiology testing market.
- The increasing demand for personalized medicine is also driving the growth of this market.
- The growing awareness about the importance of early detection and treatment in order to reduce mortality rates is also a major factor that will drive this market's growth in future years.
- Increasing government funding for research and development activities related to pharmaceutical rapid microbiology testing will also fuel its growth in future years.
- Increasing investments by private companies into research and development activities related to pharmaceutical rapid microbiology testing will also fuel its growth.
Industry Growth Insights published a new data on “Pharmaceutical Rapid Microbiology Testing Market”. The research report is titled “Pharmaceutical Rapid Microbiology Testing Market research by Types (Immunology Based Methods, Nucleic Acid Based Amplification Tests, Mass Spectrometry Based Methods, Flow Cytometry Based Methods, Growth-Based Detection Technologies, Biochemical Tests, Pharmaceutical Rapid Microbiology Testin), By Applications (Raw Material Testing, In-Process Testing, Microbial Limit Testing, Bioburden Assessment, Process Water Testing, Environment Monitoring, Sterility Testing), By Players/Companies Abbott Laboratories, Inc., Alere, Inc., Bio-Rad Laboratories, Danaher Corporation, Gen-Probe, Inc., F. Hoffman-La Roche AG, Orasure Technologies, Inc., Siemens Healthcare, Thermo Fisher Scientific, Inc., Pharmaceutical Rapid Microbiology Testin”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Rapid Microbiology Testing Market Research Report
By Type
Immunology Based Methods, Nucleic Acid Based Amplification Tests, Mass Spectrometry Based Methods, Flow Cytometry Based Methods, Growth-Based Detection Technologies, Biochemical Tests, Pharmaceutical Rapid Microbiology Testin
By Application
Raw Material Testing, In-Process Testing, Microbial Limit Testing, Bioburden Assessment, Process Water Testing, Environment Monitoring, Sterility Testing
By Companies
Abbott Laboratories, Inc., Alere, Inc., Bio-Rad Laboratories, Danaher Corporation, Gen-Probe, Inc., F. Hoffman-La Roche AG, Orasure Technologies, Inc., Siemens Healthcare, Thermo Fisher Scientific, Inc., Pharmaceutical Rapid Microbiology Testin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Rapid Microbiology Testing Market Report Segments:
The global Pharmaceutical Rapid Microbiology Testing market is segmented on the basis of:
Types
Immunology Based Methods, Nucleic Acid Based Amplification Tests, Mass Spectrometry Based Methods, Flow Cytometry Based Methods, Growth-Based Detection Technologies, Biochemical Tests, Pharmaceutical Rapid Microbiology Testin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Raw Material Testing, In-Process Testing, Microbial Limit Testing, Bioburden Assessment, Process Water Testing, Environment Monitoring, Sterility Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories, Inc.
- Alere, Inc.
- Bio-Rad Laboratories
- Danaher Corporation
- Gen-Probe, Inc.
- F. Hoffman-La Roche AG
- Orasure Technologies, Inc.
- Siemens Healthcare
- Thermo Fisher Scientific, Inc.
- Pharmaceutical Rapid Microbiology Testin
Highlights of The Pharmaceutical Rapid Microbiology Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunology Based Methods
- Nucleic Acid Based Amplification Tests
- Mass Spectrometry Based Methods
- Flow Cytometry Based Methods
- Growth-Based Detection Technologies
- Biochemical Tests
- Pharmaceutical Rapid Microbiology Testin
- By Application:
- Raw Material Testing
- In-Process Testing
- Microbial Limit Testing
- Bioburden Assessment
- Process Water Testing
- Environment Monitoring
- Sterility Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Rapid Microbiology Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical Rapid Microbiology Testing is a laboratory test that can be used to identify the presence of bacteria, fungi, and other microorganisms in pharmaceutical products.
Some of the major companies in the pharmaceutical rapid microbiology testing market are Abbott Laboratories, Inc., Alere, Inc., Bio-Rad Laboratories, Danaher Corporation, Gen-Probe, Inc., F. Hoffman-La Roche AG, Orasure Technologies, Inc., Siemens Healthcare, Thermo Fisher Scientific, Inc., Pharmaceutical Rapid Microbiology Testin.
The pharmaceutical rapid microbiology testing market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Rapid Microbiology Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Rapid Microbiology Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Rapid Microbiology Testing Market - Supply Chain
4.5. Global Pharmaceutical Rapid Microbiology Testing Market Forecast
4.5.1. Pharmaceutical Rapid Microbiology Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Rapid Microbiology Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Rapid Microbiology Testing Market Absolute $ Opportunity
5. Global Pharmaceutical Rapid Microbiology Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Type
5.3.1. Immunology Based Methods
5.3.2. Nucleic Acid Based Amplification Tests
5.3.3. Mass Spectrometry Based Methods
5.3.4. Flow Cytometry Based Methods
5.3.5. Growth-Based Detection Technologies
5.3.6. Biochemical Tests
5.3.7. Pharmaceutical Rapid Microbiology Testin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pharmaceutical Rapid Microbiology Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Application
6.3.1. Raw Material Testing
6.3.2. In-Process Testing
6.3.3. Microbial Limit Testing
6.3.4. Bioburden Assessment
6.3.5. Process Water Testing
6.3.6. Environment Monitoring
6.3.7. Sterility Testing
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pharmaceutical Rapid Microbiology Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pharmaceutical Rapid Microbiology Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pharmaceutical Rapid Microbiology Testing Demand Share Forecast, 2019-2026
9. North America Pharmaceutical Rapid Microbiology Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Application
9.4.1. Raw Material Testing
9.4.2. In-Process Testing
9.4.3. Microbial Limit Testing
9.4.4. Bioburden Assessment
9.4.5. Process Water Testing
9.4.6. Environment Monitoring
9.4.7. Sterility Testing
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Type
9.7.1. Immunology Based Methods
9.7.2. Nucleic Acid Based Amplification Tests
9.7.3. Mass Spectrometry Based Methods
9.7.4. Flow Cytometry Based Methods
9.7.5. Growth-Based Detection Technologies
9.7.6. Biochemical Tests
9.7.7. Pharmaceutical Rapid Microbiology Testin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pharmaceutical Rapid Microbiology Testing Demand Share Forecast, 2019-2026
10. Latin America Pharmaceutical Rapid Microbiology Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Application
10.4.1. Raw Material Testing
10.4.2. In-Process Testing
10.4.3. Microbial Limit Testing
10.4.4. Bioburden Assessment
10.4.5. Process Water Testing
10.4.6. Environment Monitoring
10.4.7. Sterility Testing
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Type
10.7.1. Immunology Based Methods
10.7.2. Nucleic Acid Based Amplification Tests
10.7.3. Mass Spectrometry Based Methods
10.7.4. Flow Cytometry Based Methods
10.7.5. Growth-Based Detection Technologies
10.7.6. Biochemical Tests
10.7.7. Pharmaceutical Rapid Microbiology Testin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pharmaceutical Rapid Microbiology Testing Demand Share Forecast, 2019-2026
11. Europe Pharmaceutical Rapid Microbiology Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Application
11.4.1. Raw Material Testing
11.4.2. In-Process Testing
11.4.3. Microbial Limit Testing
11.4.4. Bioburden Assessment
11.4.5. Process Water Testing
11.4.6. Environment Monitoring
11.4.7. Sterility Testing
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Type
11.7.1. Immunology Based Methods
11.7.2. Nucleic Acid Based Amplification Tests
11.7.3. Mass Spectrometry Based Methods
11.7.4. Flow Cytometry Based Methods
11.7.5. Growth-Based Detection Technologies
11.7.6. Biochemical Tests
11.7.7. Pharmaceutical Rapid Microbiology Testin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pharmaceutical Rapid Microbiology Testing Demand Share, 2019-2026
12. Asia Pacific Pharmaceutical Rapid Microbiology Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Application
12.4.1. Raw Material Testing
12.4.2. In-Process Testing
12.4.3. Microbial Limit Testing
12.4.4. Bioburden Assessment
12.4.5. Process Water Testing
12.4.6. Environment Monitoring
12.4.7. Sterility Testing
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Type
12.7.1. Immunology Based Methods
12.7.2. Nucleic Acid Based Amplification Tests
12.7.3. Mass Spectrometry Based Methods
12.7.4. Flow Cytometry Based Methods
12.7.5. Growth-Based Detection Technologies
12.7.6. Biochemical Tests
12.7.7. Pharmaceutical Rapid Microbiology Testin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pharmaceutical Rapid Microbiology Testing Demand Share, 2019-2026
13. Middle East & Africa Pharmaceutical Rapid Microbiology Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Application
13.4.1. Raw Material Testing
13.4.2. In-Process Testing
13.4.3. Microbial Limit Testing
13.4.4. Bioburden Assessment
13.4.5. Process Water Testing
13.4.6. Environment Monitoring
13.4.7. Sterility Testing
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pharmaceutical Rapid Microbiology Testing Market Size and Volume Forecast by Type
13.7.1. Immunology Based Methods
13.7.2. Nucleic Acid Based Amplification Tests
13.7.3. Mass Spectrometry Based Methods
13.7.4. Flow Cytometry Based Methods
13.7.5. Growth-Based Detection Technologies
13.7.6. Biochemical Tests
13.7.7. Pharmaceutical Rapid Microbiology Testin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pharmaceutical Rapid Microbiology Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pharmaceutical Rapid Microbiology Testing Market: Market Share Analysis
14.2. Pharmaceutical Rapid Microbiology Testing Distributors and Customers
14.3. Pharmaceutical Rapid Microbiology Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories, Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alere, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bio-Rad Laboratories
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Danaher Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Gen-Probe, Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. F. Hoffman-La Roche AG
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Orasure Technologies, Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Siemens Healthcare
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Thermo Fisher Scientific, Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Pharmaceutical Rapid Microbiology Testin
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials<
